4th Circ. Frees Pfizer From Antitrust Suit Over Celebrex Patent

Law360, New York (December 7, 2017, 3:50 PM EST) -- The Fourth Circuit on Thursday granted an unopposed motion to dismiss an antitrust suit brought against Pfizer Inc. by a putative class of health benefits plans that alleged the company used anti-competitive practices to get a patent for the inflammation medication Celebrex.

The appeals court granted the request the same day that the motion was filed. In October, the eight plans — including United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund and Wisconsin Masons’ Health Care Fund — asked the Fourth Circuit...
To view the full article, register now.